Dennis Borczon
Child & Adolescent Psychiatry · Erie, PANPI 1487625521
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $99,289 of the $120,051 with a category attached, or 82.7%. Supernus Pharmaceuticals, Inc. accounts for 67.4% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $28,919, 2.4 times the $11,972 reported in 2019. Among child & adolescent psychiatry clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 266 payments — averaging $451.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$81K
- Corium, LLC$18K
- Takeda Pharmaceuticals U.S.A., Inc.$14K
- Shire North American Group Inc$4K
- Sunovion Pharmaceuticals Inc.$3K
- Alkermes, Inc.$388
- plus $963 from 6 others
What the payments were for
- Consulting fees$3,9003%
- Speaking & faculty fees$99,28983%
- Travel & lodging$11,1339%
- Food & beverage$5,7255%
- Education$50%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 143 | $80,902 |
| Corium, LLC | 55 | $17,623 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $13,530 |
| Shire North American Group Inc | 9 | $3,814 |
| Sunovion Pharmaceuticals Inc. | 7 | $2,830 |
| Alkermes, Inc. | 4 | $388 |
| Ironshore Pharmaceuticals Inc. | 9 | $348 |
| Axsome Therapeutics, Inc. | 3 | $325 |
| Teva Pharmaceuticals USA, Inc. | 5 | $87 |
| Tris Pharma Inc | 5 | $86 |
| Collegium Pharmaceutical, Inc. | 4 | $75 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $40 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$76,279
- Azstarys$16,889
- VYVANSE$16,816
- LATUDA$2,792
- LYBALVI$480
- ARISTADA$432
- Jornay PM 20mg capsules (Bottle of 100)$244
- Auvelity$228
- ARISTADA INITIO$108
How this compares
$120,051 in reported general payments places this provider in the 95th percentile of 200 child & adolescent psychiatry providers in Pennsylvania.
See all child & adolescent psychiatry providers in Pennsylvania →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clozapine | 12 | $313 |
| Pantoprazole Sodium | 13 | $109 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Erie
- Robert WilsonErie$34K
- G Thomas-ClarkErie$6K
- Charles PerrottaErie$3K
- Brenton SongErie$3K
- David FigueroaErie$2K
- Gianpiero MartoneErie$1K
- Prianka SinhaErie$1K
- Suzanne LucotCranberry Township$72K
- Dan UdreaWexford$51K
- Craig FeasterState College$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.